Alan H. Auerbach

CIK: 0001358285

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PBYI

PUMA BIOTECHNOLOGY, INC.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (8 total)

PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 6, 2026
Sale(S)
Direct
44.1K shares at avg. $8.26$364K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 18, 2026
Award(A)
Direct
159.8K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 7, 2026
Sale(S)
Direct
18K shares at avg. $5.88$106K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 6, 2026
Sale(S)
Direct
16.9K shares at avg. $5.84$99K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 9, 2025
Sale(S)
Direct
21.6K shares at avg. $3.54$76K
PBYI
PUMA BIOTECHNOLOGY, INC.
Jul 8, 2025
Sale(S)
Direct
25.6K shares at avg. $3.53$90K
PBYI
PUMA BIOTECHNOLOGY, INC.
Feb 7, 2025
Award(A)
Direct
198.4K shares-
PBYI
PUMA BIOTECHNOLOGY, INC.
Jan 2, 2025
Sale(S)
Direct
33.8K shares at avg. $3.15$107K

		Type	Shares	Price		Ownership
Jul 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	44,058	$8.26	$364,051	Direct
Feb 18, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	159,778	-	$0	Direct
Jan 7, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	18,012	$5.88	$105,893	Direct
Jan 6, 2026	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	16,938	$5.84	$98,986	Direct
Jul 9, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	21,580	$3.54	$76,285	Direct
Jul 8, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	25,592	$3.53	$90,417	Direct
Feb 7, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Award(A)	198,399	-	-	Direct
Jan 2, 2025	PBYI PUMA BIOTECHNOLOGY, INC.	Sale(S)	33,841	$3.15	$106,657	Direct

1-8 of 8 transactions

About AUERBACH ALAN H

AUERBACH ALAN H (SEC CIK 0001358285) files insider reports with the SEC as President and CEO of PUMA BIOTECHNOLOGY, INC. (PBYI).

Signal8 holds 6 ownership filings by AUERBACH ALAN H, all Form 4s, filed between Jan 3, 2025 and Jul 8, 2026. Those filings report 8 transactions, from Jan 2, 2025 to Jul 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on AUERBACH ALAN H's filings is in LOS ANGELES, CA.

Recent filings by AUERBACH ALAN H

Jul 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Feb 18, 2026: Grant or award of PBYI shares (Form 4, code A).
Jan 7, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jan 6, 2026: Open-market sale of PBYI shares (Form 4, code S).
Jul 9, 2025: Open-market sale of PBYI shares (Form 4, code S).

Other insiders filing for PUMA BIOTECHNOLOGY, INC. (PBYI)

WILSON TROY EDWARD, Director
Cesano Alessandra, Director
HUNT DOUGLAS M
NOUGUES MAXIMO F, Chief Financial Officer
Stuglik Brian M, Director
Senderowicz Adrian, Director

How to read Form 4 transaction codes